Billings Clinic
Especially For:

Clinical Trials

Title   Head & Neck Cancer (RTOG 0920): Postoperative Radiation Therapy for Locally Advanced Resected
Description   A Randomized Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally Advanced Resected Head and Neck Cancer
IRB Number   RTOG R0920
Category   Head and Neck
Inclusion/Notes   T1 N1-2, T2-3 N0-2 M0. Hypopharynx primary and distant metastasis not eligible. Gross total resection of primary tumor with curative intent. Must have one or more of the following "intermediate" risk factors -- perineural invasion; lymphovascular invasion; single lymph node > 3 cm or >/= 2 lymph nodes (all < 6 cm) [no extracapsular extension]; close margin(s) of resection (within 5 mm of surgical margins); T3 or microscopic T4a primary tumor; T2 oral cavity cancer with > 5mm depth invasion. Dental evaluation. Positive margins, nodal extracapsular extension and/or gross residual disease after surgery are not eligible.
Status   Active
Start Date   02/12/2010
Principal Investigator (PI)   John Schallenkamp, MD
Physician Profile   Radiation Oncologist
Contact Name   Susan Dillon RN
Contact Email   sdillon1@billingsclinic.org
Phone   (406) 435-7443
Fax   (406) 435-7489
Funding Source   NCI
Print This Page
Email to a Friend
Home | Contact | Site Map | Site Privacy Policy | Terms & Conditions | Patient Privacy Policy | Medical Records | Fast Command
2800 10th Ave. North | P.O. Box 37000 | Billings, Montana 59107 | 406.238.2500
© Copyright 2014 Billings Clinic. All Rights Reserved.